Thermo Fisher Scientific Inc.
(NYSE:TMO) on Thursday reported second-quarter adjusted earnings of $6.03 per share, beating the street view of $5.71.
The life science giant’s quarterly sales of $11.994 billion increased 10% year-over-year, beating the analyst consensus estimate of $11.701 billion.
Organic revenue growth was 5%.
Customer Activity Improves Across End Markets In an earnings conference call, the company noted good customer activity continues to strengthen across end markets during the second quarter.
